682 studies found for:    Open Studies | "Vaccines"
Show Display Options
Rank Status Study
21 Recruiting Phase I/II Descending Age Study of P2VP8 Subunit Parenteral Rotavirus Vaccine in Healthy Toddlers and Infants
Condition: Evaluation of a Rotavirus Vaccine
Interventions: Biological: P2VP8 Subunit Vaccine 10mcg;   Biological: P2VP8 Subunit Vaccine 30 mcg;   Biological: P2VP8 Subunit Vaccine 60mcg;   Biological: Placebo;   Biological: Cohort B2 P2VP8 D1;   Biological: Cohort B2 P2VP8 D2
22 Unknown  Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule
Condition: Human Papillomavirus (HPV) Vaccine
Intervention: Biological: HPV-16/18 L1 VLP AS04 vaccine
23 Recruiting Immune Responses to Yellow Fever Vaccine
Condition: Prior Receipt of Yellow Fever Vaccine
Intervention:
24 Recruiting Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.
Conditions: Diphtheria;   Tetanus;   Pertussis
Interventions: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap (ADACEL);   Biological: DT vaccine (Diphtheria and Tetanus Combined Vaccine, Adsorbed);   Biological: Td vaccine (Diphtheria and Tetanus Combined Vaccine for Adults and Adolescents, Adsorbed)
25 Unknown  "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency
Condition: Common Variable Immunodeficiency
Interventions: Biological: PPS;   Biological: PnCJ PPS
26 Unknown  Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating Drugs
Condition: Vaccine Response Impaired
Intervention: Biological: hepatitis A vaccine
27 Recruiting DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants
Conditions: Diphtheria;   Tetanus;   Pertussis;   Haemophilus Influenzae Type b Infection;   Poliomyelitis;   Hepatitis B
Interventions: Biological: DTaP-IPV-Hep B-PRP~T combined vaccine;   Biological: DTaP-IPV//PRP~T and Hepatitis B vaccine
28 Not yet recruiting Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
Conditions: Adult;   Shingles;   Herpes Zoster
Interventions: Biological: Zostavax;   Biological: HZ/su vaccine;   Biological: Placebo
29 Recruiting 13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.
Condition: Pneumococcal Vaccines
Intervention: Biological: 13-valent pneumococcal conjugate vaccine
30 Recruiting Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age
Conditions: Neisseria Meningitidis;   Haemophilus Influenzae Type b
Interventions: Biological: Hib-MenCY-TT vaccine (GSK792014);   Biological: Pediarix®;   Biological: Rotarix®;   Biological: Prevnar 13®;   Biological: PedvaxHIB®;   Biological: Havrix®
31 Not yet recruiting Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
Conditions: Measles;   Mumps;   Rubella;   Varicella
Interventions: Biological: MMR Bio-Manguinhos;   Biological: MMR GlaxoSmithKline
32 Recruiting The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age
Conditions: Mortality;   Vaccines
Intervention: Biological: Providing measles vaccine for all children 9-35 months who have not yet received a routine measles vaccine
33 Recruiting A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.
Conditions: Smoking;   Vaccines
Interventions: Biological: NIC7-001;   Biological: NIC7-003;   Biological: Saline
34 Recruiting Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy
Conditions: Cancer;   Influenza Viral Infections
Interventions: Biological: Standard Trivalent Influenza Vaccine;   Biological: High-Dose Influenza Vaccine
35 Not yet recruiting Systems Biology of 23-valent Pneumococcal Polysaccharide Vaccine (PNEUMOVAX®23) and 13-valent Pneumococcal Conjugate Vaccine (PREVNAR 13®)
Condition: Pneumococcal Infection
Intervention: Biological: PNEUMOVAX and PREVNAR
36 Recruiting Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
Condition: Fever
Intervention: Other: text message surveillance for fever
37 Recruiting Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine
Condition: Infections, Meningococcal
Interventions: Biological: Meningococcal vaccine GSK134612;   Biological: Prevenar 13™
38 Recruiting A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Condition: Pneumococcal Infection
Intervention: Biological: Prevnar 13 (PVC13)
39 Recruiting Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults
Condition: Poliomyelitis
Interventions: Biological: a single dose of monovalent high-dose inactivated poliovirus type 2 vaccine (m-IPV2 HD);   Biological: a single dose of the standard trivalent inactivated poliovirus vaccine (IPV)(Imovax Polio®).
40 Recruiting Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliomyelitis;   Invasive Hib Infections
Intervention: Biological: Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years